Cargando…
Peptides as multifunctional players in cancer therapy
Peptides exhibit lower affinity and a shorter half-life in the body than antibodies. Conversely, peptides demonstrate higher efficiency in tissue penetration and cell internalization than antibodies. Regardless of the pros and cons of peptides, they have been used as tumor-homing ligands for deliver...
Autores principales: | Vadevoo, Sri Murugan Poongkavithai, Gurung, Smriti, Lee, Hyun-Su, Gunassekaran, Gowri Rangaswamy, Lee, Seok-Min, Yoon, Jae-Won, Lee, Yun-Ki, Lee, Byungheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318096/ https://www.ncbi.nlm.nih.gov/pubmed/37258584 http://dx.doi.org/10.1038/s12276-023-01016-x |
Ejemplares similares
-
Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice
por: Khan, Fatima, et al.
Publicado: (2021) -
Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2022) -
Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer
por: Gangadaran, Prakash, et al.
Publicado: (2022) -
A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1–Overexpressing Tumors In Vivo
por: Haque, Md. Enamul, et al.
Publicado: (2019) -
Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy
por: Yoo, Jae Do, et al.
Publicado: (2020)